Article Information
History
- September 15, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Emma Pritchard1,2,*,
- Karina-Doris Vihta1,2,3,
- David W. Eyre2,4,5,
- Susan Hopkins2,6,7,
- Tim EA Peto1,2,4,8,
- Philippa C. Matthews1,9,10,11,
- Nicole Stoesser1,2,4,8,
- Ruth Studley12,
- Emma Rourke12,
- Ian Diamond12,
- Koen B. Pouwels2,13,#,
- Ann Sarah Walker1,2,4,#,
- the COVID-19 Infection Survey Team
- 1Nuffield Department of Medicine, University of Oxford, Oxford, UK
- 2The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK
- 3Department of Engineering, University of Oxford, Oxford, UK
- 4The National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, UK
- 5Big Data Institute, Nuffield Department of Population Health, University of Oxford, Oxford, UK
- 6Healthcare-Associated Infection and Antimicrobial Resistance Division, Public Health England, London, UK
- 7National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK
- 8Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK
- 9Francis Crick Institute, London, UK
- 10Division of Infection and Immunity, University College London, London UK
- 11Department of Infection, University College London Hospitals, London, UK
- 12Office for National Statistics, Newport, UK
- 13Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK
- ↵*Corresponding author; email: emma.pritchard{at}ndm.ox.ac.uk
↵# contribution considered equal
Posted September 15, 2022.
Detecting changes in population trends in infection surveillance using community SARS-CoV-2 prevalence as an exemplar
